Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00514865 · ClinicalTrials.gov registry record · Phase 2
Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder
A Phase 2 study, sponsored by Ono Pharma USA.
- Completed
- Registry status
- Phase 2
- Development phase
- 278
- Enrollment target
NCT00514865: Completed Phase 2 study, sponsored by Ono Pharma USA.
NCT00514865 is a Phase 2 study that has completed, run by Ono Pharma USA. The registered enrollment target is 278 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (109% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00514865, a Phase 2 study, has completed, sponsored by Ono Pharma USA.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 278 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients with Recurrent Major Depressive Disorder
Interventions
- DRUG Placebo
- DRUG ONO-2333Ms Experimental 2
- DRUG ONO-2333Ms Experimental 1
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 278 participants |
| Start Date | 2007-06-13 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
What the finished NCT00514865 record still lists
NCT00514865 is an interventional study that assigns participants to a tested intervention. The registered 278 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (109% higher).
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00514865 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00514865 about?
NCT00514865 is a clinical study titled "Placebo-Controlled Study of ONO-2333Ms in Patients With Recurrent Major Depressive Disorder". The purpose of this study is to evaluate the safety and efficacy of ONO-2333Ms in patients with Recurrent Major Depressive Disorder
What is the current status of trial NCT00514865?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 278 participants. The study started on 2007-06-13. Estimated completion is 2008-06.
What interventions are being tested in trial NCT00514865?
The interventions under investigation include: Placebo (DRUG), ONO-2333Ms Experimental 2 (DRUG), ONO-2333Ms Experimental 1 (DRUG).
Who is sponsoring clinical trial NCT00514865?
This trial is sponsored by Ono Pharma USA, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00514865's enrollment target sits among peer trials
278 202nd of 2000 higher than 1,799 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04586959 · 278 participants · NA
Uterine Manipulation During Minimally Invasive Surgery for Early Stage Endometrial Cancer
- NCT05010148 · 278 participants · Phase 3
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
- NCT05489237 · 278 participants · Phase 1
First-in-human Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors
- NCT05965245 · 278 participants · NA
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI